Hillsdale Investment Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-7,730
Closed -$683K 670
2020
Q3
$683K Buy
+7,730
New +$683K 0.07% 267